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Abstract 
We conducted a systematic review and meta-analysis of randomized clinical trials examining the 
effect of inorganic nitrate or nitrite supplementation on cognitive function (CF) and cerebral 
blood flow (CBF). Two databases (PubMed, Embase) were searched for articles from inception 
until May 2017. Inclusion criteria were: randomized clinical trials; participants >18 years old; 
trials comparing a nitrate/nitrite intervention with a control. Thirteen and nine trials were 
included in the meta-analysis to assess CF and CBF, respectively. Random-effects models were 
used and the effect size described as standardized mean differences (SMDs). A total of 297 
participants (median of 23 per trial) were included for CF; 163 participants (median of 16 per 
trial) were included for CBF. Nitrate/nitrite supplementation did not influence CF (SMD +0.06, 
95% CI: -0.06, 0.18, P =0.32) or CBF under resting (SMD +0.14, 95% CI: -0.13, 0.41, P =0.31), 
or stimulated conditions (SMD +0.23, 95% CI: -0.11, 0.56, P =0.19). The meta-regression 
showed an inverse association between duration of the intervention and CBF (P =0.02) but no 
influence of age, BMI or dose (P < 0.05). Nitrate and nitrite supplementation did not modify 
CBF or CF. Further trials employing larger samples sizes and interventions with longer duration 
are warranted.  
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Introduction  
Cognitive impairment and dementia are global health challenges because of the costs associated 
with management and treatment, severity of symptoms for the affected individual and impact on 
patients’ families, carers and communities (Wortmann, 2012). Furthermore, the prevalence of 
people diagnosed with dementia is rising at an alarming rate, with a recent report estimating that 
by 2050 the total number of individuals living with dementia worldwide will increase from 47 to 
131 million (Prince et al., 2016). Therefore, effective interventions to prevent cognitive decline 
and dementia onset are a global research priority.  
A major risk factor for cognitive decline is thought to be inadequate nitric oxide (NO) 
availability (de la Torre & Stefano, 2000; Toda et al., 2009). NO is a free radical soluble 
gasotransmitter with pleiotropic actions, of which several are integral to normal cognitive 
function (CF), including regional blood flow, immune-surveillance, metabolic efficiency, 
glucose homeostasis, and neurotransmission (Toda et al., 2009; Weitzberg & Lundberg, 2013). 
NO availability is determined by the activity of NO synthases (NOS), which are widely 
distributed across tissues in different isoforms (endothelial, inducible, neuronal) (Lundberg et al., 
2008; Weitzberg & Lundberg, 2013). In cognitive decline, NO generation via these pathways 
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becomes dysregulated resulting in chronic hypo-perfusion, neurodegeneration and impaired 
cognitive ability (de la Torre & Stefano, 2000; Toda et al., 2009).  
NO can also be produced by a distinct alternative pathway involving the conversion of nitrate 
into nitrite and NO via a series of reducing reactions (Lundberg et al., 2008; Zweier et al., 1995). 
Both nitrate and nitrite are present in a wide range of concentrations in a variety of foods with 
the higher content found in green leafy vegetables, beetroot, or meat products that have had 
nitrite salts added as preservatives (Lidder & Webb, 2013). In the past decade, it has emerged 
that increasing nitrate and nitrite ingestion may improve vascular and metabolic outcomes via 
increased generation of NO (Weitzberg & Lundberg, 2013). More recent evidence also indicates 
potentially beneficial effects of both compounds, administered as ionic salts or nitrate-rich food 
products, on cognition and brain metabolic and vascular health (Clifford et al., 2015; Gilchrist et 
al., 2014; Justice et al., 2015; Presley et al., 2011; Wightman et al., 2015). Such effects could be 
due to improved NO-mediated synaptic activity and/or as a consequence of increased cerebral 
blood flow (CBF) and thus a better coupling of blood flow to metabolism (Presley et al., 2011; 
Toda et al., 2009; Aamand et al., 2013).  
Mechanistic support for the latter hypothesis in humans has been provided by Presley and 
colleagues (2011), who observed that a diet rich in nitrate-containing foods (e.g., green leafy 
vegetables) stimulated cerebral perfusion in the prefrontal cortex of elderly adults, the region of 
the brain associated with executive function, working memory, and other processes reliant on 
cognitive ability. However, subsequent studies measuring CBF, or directly measuring CF, after 
inorganic nitrate or nitrite ingestion have produced mixed findings, possibly because of the small 
size and diversity of study designs employed (Clifford et al., 2015; Kelly et al., 2013). Thus, 
despite the therapeutic potential, it remains unclear whether augmenting NO bioavailability with 
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either nitrite salts or nitrate-rich foods is an effective strategy for increasing CBF and/or 
mitigating cognitive deficits.  
Consequently, we undertook a systematic review and meta-analysis of randomised clinical trials 
(RCTs) examining the efficacy of inorganic nitrate and nitrite supplementation on CBF and CF 
in adult participants with and without medical conditions. We set out to determine whether the 
ingestion of nitrite-salts or nitrate-rich foods (i.e., beetroot, spinach, rocket, lettuce, cabbage; 
Lidder & Webb, 2013) augments CBF and improves CF and to estimate effect sizes. We also 
examined whether test conditions (e.g., exercise vs. rest), age, body mass index (BMI), 
supplement dose, quality of the studies and intervention duration modified the effects of 
inorganic nitrate or nitrite on CBF and CF. These results will help to inform whether nitrate or 
nitrite supplementation holds promise as a relatively inexpensive strategy for augmenting CBF 
and combatting cognitive decline. 
Methods  
The present systematic review was conducted according to the Cochrane guidelines and it is 
reported according to PRISMA guidelines (Higgins & Green, 2011; Liberati et al., 2009). The 
protocol of the systematic review is available on request. 
Literature search: Two databases (PubMed, Embase) were searched for articles from inception 
until May 2017. In addition, included reviews and eligible full text articles were searched 
manually to identify other suitable articles to be included in the systematic review. The following 
terms and keywords were entered and Boolean terms were used to increase sensitivity of the 
search strategy: nitrate, nitrite, beetroot, rocket, cabbage, lettuce, spinach, green leafy vegetables, 
cognition, brain, dementia, cerebral, memory, executive, attention, motor skills, blood flow, 
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vascular flow, perfusion. A summary of the specific search algorithms is reported in the Online 
Supplementary Material (Box 1). 
Study selection: Titles and abstracts were screened using pre-defined eligibility criteria in 
accordance with the PICOS (population, intervention, comparator, outcome, study design) 
framework (Table S1 of the Online Supplementary Material) before retrieval of the full-text 
articles. The following inclusion criteria were used to assess the eligibility of articles for 
inclusion in this systematic review: 1) randomised controlled trials (no exclusion criteria were 
used for study design, or blinding); 2) trials recruiting adult participants (≥18 years) and no 
exclusion criteria were applied in relation to participants’ health status; 3) trials based on nitrate 
or nitrite supplementation were included if they provide information on the type of nitrate salt 
(potassium or sodium), dose, formulation, frequency and route of administration. A list of .the 
inclusion and exclusion criteria is provided in the Online Supplementary Material (Box 2). Trials 
based on beet root juice supplementation or ingestion of nitrate-rich foods were included in the 
analyses if they provided information on the frequency and amount of nitrate-containing food 
provided; 4) trials reporting effects of nitrate or nitrite on global and domain-specific CF and 
CBF measured by different techniques including magnetic resonance imaging (MRI), ultrasound 
or near infrared spectroscopy (NIRS); 5) English-language restriction but not time restriction was 
applied in searching the databases; 6) Full text papers and abstracts  were included (if they 
contained sufficient information to complete qualitative and quantitative analysis). Two 
investigators (TC, OS) independently evaluated the titles and abstracts to check eligibility for 
inclusion. If the reviewers agreed, each article was either excluded or moved to the next stage 
(full-text). If agreement was not achieved, the article was moved for evaluation after retrieval of 
the full-text. The selected full-texts were then reviewed to confirm their inclusion in the 
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systematic review. Disagreements were discussed with a third reviewer (MS) and resolved by 
consensus.   
Data extraction: Relevant information was extracted and tabulated separately for CF and CBF. 
If information was not available from the full text, authors were contacted to obtain the relevant 
data.  
Cognitive function: The following information was extracted independently by two 
investigators (AB, TC) from eligible articles: 1) authors and year of publication; 2) study 
characteristics (design, sample size); 3) participant characteristics (age, male/female ratio, health 
status and baseline values for BMI; 4) route, dose and duration of inorganic nitrate and nitrite 
supplementation; and 5) cognitive tests and exercise condition. Any disagreements in data 
extraction were resolved through discussion until consensus was reached.  
Cerebral blood flow: Two independent reviewers (AB, MS) extracted relevant information 
from the eligible articles: 1) authors and year of publication; 2) study characteristics (design, 
sample size); 3) participant characteristics (age, male/female ratio, health status and baseline 
values for BMI, and 4) route, dose and duration of inorganic nitrate/ nitrite supplementation 5) 
method to assess cerebral blood flow (CBF) and testing conditions (i.e., exercise, mental 
stimulation). Any disagreements in data extraction were resolved through discussion until 
consensus was reached. 
Quality Assessment: The modified Jadad score was applied to evaluate the risk of bias of the 
trials. Specific questions linked to randomisation procedure, blinding and description of dropout 
or attrition rates were used rank the quality of the trials (Jadad et al., 1996). Scores ranged from 0 
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to 5; a score less than 3 indicates a low quality trial where a score greater or equal to 3 indicates 
high quality trial. 
Statistical Analysis  
The primary outcomes of the meta-analysis were changes in CF and CBF after inorganic nitrate 
or nitrite supplementation. Random effect models were applied to address the heterogeneity 
related to differences in study design and application of different and concomitant methods for 
the evaluation of CF and CBF. In addition, some trials used several cognitive tests to assess 
domain-specific changes in CF and CBF, as shown in Table 1 and 2. This may lead to reduced 
independence of measurements and to consequential over-estimation of the effect size derived 
from the meta-analysis. These methodological aspects were taken into account into the analysis 
by averaging the standardised effect sizes for each trial with the aim of providing a more 
conservative estimate of the effect size. Forest plots were created to summarise and illustrate the 
individual and overall effects of inorganic nitrate and nitrite supplementation on CF and CBF. 
The meta-analysis was conducted using Comprehensive Meta-Analysis software (Biostat, 
Engelwood, New Jersey). Results are described as standardized mean differences (SMDs) and 
95% confidence intervals (95%CI). If data were not available in the main text or in tables, 
figures were used to extract the information.  
Sensitivity analyses were performed to investigate whether the effects of inorganic nitrate and 
nitrite supplementation on CF and CBF were influenced by testing conditions (i.e., exercise or 
mental stimulation). A random-effect meta-regression model was applied to examine the 
associations between effect sizes for CF and for CBF and age, BMI, dose of nitrate/nitrite 
supplementation, duration of the trial and Jadad score. Funnel plots and Egger’s regression tests 
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were performed to evaluate the publication bias (Egger et al., 1997). Heterogeneity was assessed 
by using Cochrane Q statistic; P > 0.1 indicates significant heterogeneity. The I2 test was utilised 
to assess heterogeneity across trials where a value < 25% indicates low risk, 25-75% indicates 
moderate risk, and >75% indicates a high risk (Higgins et al., 2003).   
 
 
Results  
Search results 
The screening process and the number of the studies included in the systematic review are 
described in Figure 1. The initial search of the two electronic databases produced 12865 articles 
which was reduced to 5387 after the deletion of duplicates. No relevant studies were found by 
manual search of relevant reviews and studies. After the first title and abstract selection phase, 
23 full-text articles were identified for further assessment and, from these, 18 trials were 
included in the systematic review. Thirteen trials and nine trials were included in the meta-
analysis to investigate effects of nitrate and nitrite supplementation on CF and CBF, respectively. 
Cognitive Function 
Studies characteristics: The trials included in the systematic review reported on a total of 297 
participants with a median of 23 (range 10-48) participants per trial.  The median age of the 
participants was 36 (range 21 – 73) years. The systematic review includes 2 parallel and 11 
crossover trials and 12 of them were double-blind. Six of these studies included an exercise 
component as part of the protocol to evaluate the effects of dietary nitrate and nitrite on CF at 
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rest and during exercise. The large majority (12 of 13 studies) supplemented with nitrate or 
nitrate-rich foods; eleven trials used beetroot and one trial used spinach as sources of inorganic 
nitrate, and one study supplemented with sodium nitrite (see Table 1). As placebo, eight trials 
used nitrate-depleted beetroot juice (Kelly et al., 2013; Gilchrist et al., 2014; Lefferts et al., 2015; 
Rattray et al., 2015; Thompson et al., 2015; Thompson et al., 2016; Vanhatalo et al., 2016; 
Shannon et al., 2017), one studied employed nitrite-free capsules (Justice et al., 2015), two trials 
combined apple and blackcurrant juice (Thompson et al., 2014; Whitman et al., 2015) and one 
study did not report information on the control group (Bondonno et al., 2014).  
Participant health status and intervention duration: Two trials included patients with type 2 
diabetes (T2DM) (Gilchrist et al., 2014; Shepherd et al., 2015), four trials included middle-aged 
and older healthy participants (Kelly et al., 2013; Bondonno et al., 2014; Justice et al., 2015;  
Vanhatalo et al., 2016) and the remaining seven trials recruited young healthy participants 
(Table 1). The median BMI of the adults included in the trials was 24.6 kg/m
2
 (range: 24.0 – 
30.8 kg/m
2
). The duration of interventions ranged from 90 minutes to 10 weeks but ten trials (out 
of 13) had a duration less than 7 days. For nitrate supplementation studies, the median dose of 
inorganic nitrate provided was 7.2 mmol/day (range: 2.9 – 12.8 mmol/day); the trial using nitrite 
supplemented with 2.4 mmol/day of sodium nitrite (Justice et al., 2015).  
The greatest source of heterogeneity in the CF trials was the type of cognitive assessment with 
23 different tests being reported. Three trials used a single CF test (Rattray et al., 2015; 
Thompson et al., 2015; Vanhatalo et al., 2016) whereas one trial employed eight different CF 
tests (Lefferts et al., 2015). A summary of the distribution of cognitive tests per trial is provided 
in Table 1 whereas the frequency of application of each test across all the trials is summarised in 
Figure S1 of the Online Supplementary Material.  
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Meta-analysis: Overall, inorganic nitrate or nitrite supplementation did not improve CF (SMD 
+0.06, 95% CI: -0.06, 0.18, P = 0.32) and we observed no significant heterogeneity between 
studies (I2 = 0%; P = 0.68) (Figure 2). However, the only study which supplemented healthy 
older individuals with inorganic nitrite for 10 weeks reported a significant improvement in CF 
(Justice et al., 2015). When stratified by inclusion of exercise testing in the protocols, there was 
no significant effect of inorganic nitrate supplementation in either the exercise (N=6, SMD 
+0.13, 95% CI: -0.05, 0.32, P = 0.16) or non-exercise (N=7, SMD +0.02, 95% CI: -0.15, 0.21, P 
= 0.76) trials. Meta-regression analysis did not reveal any significant association between  CF 
effect size and age (β: -0.002, SE: 0.003, P = 0.33), BMI, (β: -0.02, SE: 0.02, P = 0.23), dose (β: 
0.002, SE: 0.004, P = 0.63), study duration (β: 0.0005, SE: 0.0002, P = 0.07) or Jadad score (β: 
0.09, SE: 0.18, P = 0.09) (Table 3).  
Study Quality and Publication bias: The quality of the trials ranged from 2 to 5 (median: 3) on 
the Jadad score and only one study had a score < 3 (Bondonno et al., 2014), indicating the 
overall high quality of the trials (Table 1). Visual inspection of the Funnel Plot revealed a study 
with a large positive effect size and the presence of publication bias was also confirmed by the 
Egger’s Regression test (p=0.01; Figure S3 of the Online Supplementary Material). Exclusion 
of the study (Justice et al., 2015) with the largest positive effect size removed the publication 
bias (N=12, Egger’s test, P=0.13).  
Resting and Stimulated CBF 
Studies characteristics: Nine trials assessed changes in CBF in resting conditions and included a 
total of 163 participants (sample size range: 10 – 40); the overall median age of the participants 
was 22 years (range 20 – 70). Five of these studies also assessed CBF under stimulated 
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conditions (i.e., exercise (Bond et al., 2013; Curry et al., 2016; Lefferts et al., 2016; Thompson et 
al, 2014), or mental stimulation (Wightman et al., 2015)). 
One study employed a parallel study design (Whitman et al., 2015) whereas all remaining eight 
trials used a cross-over design (Aamand et al., 2013; Bond et al., 2013; Chirinos et al., 2017; 
Curry et al., 2016; Lefferts et al., 2016; Presley et al., 2011; Rattray et al., 2015; Thompson et al, 
2014) (Table 2). Most studies (seven) used beetroot juice as a source of inorganic nitrate but 
high nitrate foods or sodium nitrite were also used in some studies (Table2).  
Cerebral blood flow tests: Four studies reported the effect of inorganic nitrate supplementation 
on middle cerebral artery blood flow velocity (MCAV) (Aamand et al., 2013; Curry et al., 2016; 
Lefferts et al., 2016; Rattray et al., 2015) and two reported the effect of inorganic nitrate on CBF 
measured by arterial spin labelling (Presley et al., 2011; Aamand et al., 2013). Additional 
measurements used to assess CBF included Near Infrared Spectroscopy (Thompson et al, 2014; 
Whitman et al., 2015), cerebrovascular resistance index by Transcranial Doppler 
Ultrasonography (Bond et al. 2013) and evaluation of changes in Carotid Characteristic 
Impedance, Carotid Cross-Sectional Area and Carotid Bed Vascular Resistance (Chirinos et al., 
2017). The frequency of application of each method across all the trials is summarised in Figure 
S2 of the Online Supplementary Material. 
Participant health status and intervention duration: Eight trials recruited healthy individuals and 
one trial recruited patients with heart failure (Chirinos et al., 2017) (Table 2). The duration of the 
inorganic nitrate supplementation ranged from 3 hours to 3 days. The dose of inorganic nitrate 
ranged from 5.5 to 24 mmol/day (median dose: 9.8 mmol/day).   
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Meta-analysis:  Overall, inorganic nitrate did not improve CBF under either resting (SMD +0.14, 
95% CI: -0.13, 0.41, P = 0.31), or under stimulated conditions (SMD +0.23, 95% CI: -0.11, 0.56, 
P = 0.19). We observed moderate heterogeneity between studies testing the effect of inorganic 
nitrate on CBF at rest and stimulated conditions (I2 = 56.7%; P = 0.01; I2 = 44.1 %; P = 0.12, 
respectively) (Figure 3). Meta-regression analysis produced no evidence for significant 
associations of resting CBF effect size with age (β: 0.001, SE: 0.006, P = 0.98), BMI, (β: 0.016, 
SE: 0.019, P = 0.41), dose (β: -0.01, SE: 0.019, P = 0.58), or Jadad score (β: 0.03, SE: 0.13, P = 
0.79). However, there was a significant negative association between CBF effect size and study 
duration (β: -0.001, SE: 0.0006, P = 0.02) (Table 3).  
Study Quality and Publication bias: The quality of the trials ranged from 2 to 4 (median: 2) 
according to the Jadad score. On this scoring system, 4 studies showed a score ≥ 3 (Chirinos et 
al., 2017; Lefferts et al., 2015; Thompson et al, 2014; Wighman et al., 2015) (Table 2). We 
could not assess the quality of one study (Rattary et al., 2015), as it was an abstract. Visual 
inspection of the Funnel Plot revealed no evidence of publication bias and this was confirmed by 
the Egger’s Regression test for both resting (p=0.43) and stimulated |(p=0.58)  CBF; Figure S4 
and S5 of the Online Supplementary Material).  
Discussion  
Our meta-analysis revealed that inorganic nitrate or nitrite supplementation was not associated 
with improved CF or increased CBF. The combined standardized mean difference (placebo vs. 
intervention) was +0.06 for CF and +0.14 and +0.23 for CBF at rest and in simulated conditions, 
respectively. These findings were not influenced by whether the tests were performed at rest, 
during exercise or with mental stimulation, by the  age or health status of the participants or by 
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the dose of inorganic nitrate or nitrite. Overall, the studies had small sample sizes and were of 
short duration, making it difficult to draw definitive conclusions about the efficacy of inorganic 
nitrate or nitrite in modulating CF and CBF.  
The quality of the studies assessing CF was generally high; all studies employed a randomized 
design, used appropriate interventions, and in all but one of these studies (Bondonno et al., 2014) 
the intervention agent was provided in a double-blind fashion. Similarly, with the exception of 
one study, those assessing effects on CBF were all randomized, crossover trials. However, only 6 
of the 9 trials were double-blind so that (along with other factors) meant they were generally of 
lower quality than those assessing effects on CF (Table 2). The overall utility of all the included 
trials was severely limited by the small sample sizes. Indeed, only 2 of the 21 studies reported 
that they had conducted an a priori power analysis to determine if they had an adequate sample 
size to detect a treatment effect for CF or CBF. One of these studies (Bondonno et al., 2014), 
suggested that at 80% power, 30 participants was sufficient to detect subtle treatment effects 
(e.g., 27 ms in simple reaction time) in various cognitive tasks. Given that the median sample 
size in the studies that assessed CF was only 23, it would be reasonable to assume that many of 
the studies were not adequately powered to detect potential effects of the nitrate or nitrite 
interventions, and that the risk of type 2 errors was high. In view of this, it is vitally important 
that future studies include larger sample sizes and ensure they are sufficiently powered to detect 
anticipated nitrate/nitrite-induced changes in CBF or CF.  
The participants in most studies were of normal BMI, male, healthy, and not suffering from a 
cognitive-related disease. Of the two studies that examined effects of inorganic nitrate or nitrite 
on CF in a non-healthy cohort (T2DM patients), one observed improvements following the 
intervention (Gilchrist et al., 2014) and one did not (Shepherd et al., 2015). All remaining 11 
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trials that investigated effects of nitrate/ nitrite supplementation on CF were performed in 
participants with a BMI ≤25 kg∙m2. Because obesity is associated with impaired NO availability, 
it could be argued that individuals with a BMI ≥30 kg∙m2 might be more responsive to nitrate or 
nitrite induced vascular or metabolic effects (Ashor et al., 2016). Conversely, consequent to their 
greater body mass, it is possible that obese individuals will require a larger absolute nitrate/nitrite 
dose to manifest meaningful physiological changes. Prescribing a nitrate dose relative to body 
mass could help ameliorate this issue. Future studies should compare the effects of nitrate or 
nitrite supplementation on CF in both normal weight and obese individuals. As for studies that 
assessed effects on CF, only one study assessed effects of inorganic nitrate supplementation on 
CBF in non-healthy, obese participants. Chirinos and colleagues (2017) examined the effects of 
nitrate-rich beetroot juice in heart failure patients, and observed no significant changes in carotid 
artery hemodynamics. Arguably, older individuals suffering from a disease — especially a 
diagnosed cognitive disorder — are more likely to benefit from an intervention attempting to re-
establish a dysfunctional pathway than young, healthy individuals, in whom NO availability is 
less likely to be impaired. Thus, it would seem prudent that future research prioritizes studying 
the effects of inorganic nitrate and nitrite supplementation on CF and CBF with older individuals 
with some cognitive dysfunction e.g. mild cognitive impairment or subjective memory 
complaints. In addition, few studies were carried out using female participants. Although there is 
no strong a priori rationale to anticipate that the impact of such supplementation would differ by 
sex, future studies should address potential effects in women. 
Our meta-regression showed that the duration of the nitrate or nitrite supplementation had a 
modest influence on CBF. More specifically, the longer the duration of the supplementation, the 
smaller was the improvement in CBF. However, this observation should be interpreted with 
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caution because the majority of the trials had a very short duration. Of the nine studies assessing 
effects on CBF, only two provided the supplement for >150 min pre-assessment — and both 
displayed positive effects. The first, by Presley et al., (2011), was a randomized crossover trial in 
which healthy older adults received either a low nitrate or high nitrate diet for 2 days prior to 
measurements of cerebral perfusion using magnetic resonance imaging (MRI). Those in the high 
nitrate diet (12.6 mmol/day) group had a substantial and preferential increase in frontal cortex 
perfusion compared to those in the low nitrate diet group (0.9 mmol/day). The other study, by 
Aamand and colleagues, (2013) found that 3 days of sodium nitrate (vs. nitrate-free saline) 
decreased the haemodynamic lag of the blood oxygenation level dependent (BOLD) response in 
the visual cortex of healthy, young males (Table 2). However, CBF, as measured by MRI, was 
unchanged. Clearly, more studies with longer supplementation periods are required before we 
can establish whether duration moderates the efficacy of nitrate/nitrite on CBF.  
Most of the studies provided nitrate in the form of beetroot juice or nitrate-rich foods such as 
green leafy vegetables. Given only two studies assessed the effects of nitrate/ nitrite salts on CF 
or CBF, it was not possible to examine whether the vehicle for nitrate delivery (i.e., nitrate salts 
or nitrate-rich vegetable products) influenced the efficacy of supplementation. Interestingly, 
however, compared with nitrate salts, recent studies have reported greater effects of nitrate-rich 
vegetable products on blood pressure (Jonvik et al., 2016), the oxygen cost of exercise (Flueck et 
al., 2015), and post-exercise recovery (Clifford et al., 2017).  This suggests possible additive or 
synergistic effects between nitrate and other plant-based compounds. Indeed, several plant-based 
compounds other than nitrate have potential benefits on CF and CBF (Ide et al., 2014; Desideri et 
al., 2012; Macready et al., 2009). These compounds include polyphenols, such as catechins, 
anthocyanins, and other flavonoids, and carotenoids (Macready et al. 2009; Gómez-Pinilla, 
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2008) that are purported, at least in part, to exert their beneficial effects on CBF and CF through 
NO-dependent mechanisms, namely increased vasodilative effects (Sokolov et al., 2013). To our 
knowledge, there is no evidence to suggest that beetroot, the main vehicle used in the RCTs 
included in this analysis, contains high quantities of the polyphenolic compounds showing 
potential for cognitive modulation. Indeed, the most abundant bioactive compound in beetroot, 
other than nitrate, is betanin and, to date, its effects on cognitive function are unknown. 
Notwithstanding, we acknowledge that the current evidence makes it impossible to differentiate 
the effects of nitrate/nitrite salts and nitrate-rich plants on cognitive function, the latter of which 
contains additional bioactive compounds. The independent effects of the bioactive compounds 
and the nitrate/nitrite in these foods is an important question for future research.  
Our study also has a number of other limitations. Firstly, because such a wide range of 
assessments and methods were used to evaluate CF, several of which were domain-specific (e.g., 
reaction time vs. working memory), pooling the average effect size for all tests overlooks 
potential changes for isolated tests. This is illustrated by the fact that when each cognitive test 
was modelled as an independent outcome in the meta-analysis, nitrate supplementation showed a 
modest benefit for CF (data not shown). Nonetheless, this latter finding, in which all tests are 
considered independently, can overestimate the effect size; hence, to provide a more 
conservative estimate, we chose to use the average effect size from each study as our main 
outcome measure. Secondly, we observed moderate heterogeneity between studies for CBF, 
likely because of the wide variability in participant age and health status, CBF measures used, 
and the dose and duration of the nitrate/nitrite interventions used in each study. As outlined in a 
recent commentary (Barnard et al., 2017), heterogeneity between studies may disguise the 
benefits observed in single, well-controlled studies that, under specific conditions (e.g., dose, 
 
 
 
 
 
 
 
18 
 
duration, population) demonstrated real effects. This possibility needs to be taken into 
consideration when interpreting our findings.   
Conclusions: In conclusion, there is no robust evidence that inorganic nitrate or nitrate 
supplementation influences CBF or CF. However, these findings might not be generalizable to 
older people, those with higher adiposity or and those with reduced cognitive ability;  all of the 
included studies were performed in individuals <75 years old. In addition, all available trials 
were characterized by small sample sizes and short intervention durations and, thus, most of the 
studies may not have been designed optimally to observe any potential benefits. Consequently, 
the main conclusion of this study is that there is insufficient evidence to know whether 
supplemental inorganic nitrate or nitrite could improve CF or enhance CBF. Given the interest in 
use of non-pharmacological approaches for maintenance and improvement of cognitive function 
during ageing and the mechanistic rational for potential benefits of enhanced NO availability, 
further well-controlled and sufficiently powered trials, especially in more at-risk populations, 
with longer duration of nitrate/ nitrate supplementation, need to be conducted.  
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Figure Legends 
 
Figure 1: Flow diagram of the process used in selection of the randomised controlled trials 
included in this systematic review and meta-analysis 
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Figure 2: Forest plots showing the effect of dietary nitrate and nitrite supplementation on 
cognitive function.  
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Figure 3: Forest plots showing the effect of dietary nitrate and nitrite supplementation on 
cognitive function, cerebral blood flow at rest (A) and in stimulated conditions (B).  
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Table 1: Characteristics of the studies included in the systematic review and meta-analysis of the 
effects of dietary nitrate/nitrite on cognitive function 
Autho
r  
(year) 
Co
unt
ry 
Stud
y 
Desi
gn 
Sam
ple 
Size 
Health 
Status 
Age 
(yea
rs) 
M
al
es 
Nitrate 
Dose 
(mmol/d
ay) 
Type 
of 
Interve
ntion 
Pl
ac
eb
o 
Duration 
of 
intervent
ion 
Base
line 
BMI 
(Kg/
m2) 
Cognitive Tests Exerci
se 
Testin
g? 
Ja
d
a
d 
S
c
or
e 
Bond
onno, 
2014 
Au
str
ali
a 
CO, 
R, 
UB 
30 Healthy 
Middle-
Aged 
47.
3 
6 2.9  SP - 150 min 23.6 SRT, DV, 
CRT, SM, 
NWM, DWR 
NO 2 
Gilchr
ist, 
2014 
U
K 
DB, 
CO, 
R, Pl 
27 T2DM 67.
2 
1
8 
7.5 BJ N
D-
BJ 
14 days 30.8 SRT, SM, 
RVIP, DRT, 
SPM 
NO 3 
Justic
e, 
2015 
US
A 
DB, 
P, Pl, 
R 
30 Healthy 
Older 
62 1
6 
1.2/2.4 SN N
F-
C 
10 
weeks 
24.9 TMT-A 
TMT-B 
NO 4 
Kelly, 
2013 
U
K 
DB, 
CO, 
R, Pl 
12 Healthy 
Older 
64 6 9.6 BJ N
D-
BJ 
3 days 24.1 RVIP, SS, NR NO 3 
Leffer
ts, 
2015 
US
A 
DB, 
CO, 
R, Pl 
20 Healthy
, Young 
23 2
0 
6.5-7.0 BJ N
D-
BJ 
120 min 24.6 MR, ER, DV, 
AST, CRT, 
MZ, CPT, 
GNG 
YES 3 
Rattra
y, 
2015a 
Au
str
ali
a 
DB, 
CO, 
R, Pl 
12 Healthy
, Young 
- - 12 BJ N
D-
BJ 
120 min - CST YES - 
Shann
on, 
2017 
U
K 
DB, 
CO, 
R, Pl 
10 Healthy
, Young 
23 1
0 
12.5 BJ N
D-
BJ 
175 min 23.9 SST, AST, 
RVIP 
YES 3 
Sheph
erd, 
2015a 
U
K 
DB, 
CO, 
R, Pl 
48 T2DM 63.
3 
3
5 
6.4 BJ N
D-
BJ 
4 days 30.1 SRT, SM, CST NO  
Thom
pson, 
2015 
U
K 
DB, 
CO, 
R, Pl 
16 Healthy
, Young 
24 1
6  
12.8  BJ N
D-
BJ 
7 days 24.6 CST, DRT YES 3 
Thom
pson, 
2014 
U
K 
DB, 
CO, 
R, Pl 
16 Healthy
, Young 
24 1
6 
5 BJ B
CJ
+
AJ 
90 min 24.1 RVIP, CST YES 3 
Thom
pson, 
2016 
U
K 
DB, 
CO, 
R, Pl 
36 Healthy
, Young 
24 3
6  
6.4 BJ N
D-
BJ 
5 days 24.6 CST YES 3 
Vanh
atalo, 
2016a 
U
K 
DB, 
CO, 
R, Pl 
30 Healthy 
Older 
73 1
0 
12 BJ N
D-
BJ 
10 days 25 RVIP NO - 
Wight
man, 
2015 
U
K 
P, 
DB, 
R, Pl 
40 Healthy
, Young 
21 1
2 
5.5 BJ B
CJ
+
AJ 
90 min 24 SS, RVIP, 
MFT 
NO 3 
BCJ+AJ, blackcurrant cordial JUICE and apple juice; BMI, body mass index; CAD, coronary artery diseases; CO, crossover; Conc, 
concentration; DB, double-blind; NF-C, nitrite free capsules; P, Parallel; Pl, placebo-controlled; R, Randomized SB, single-blind; SN, 
Sodium Nitrite; SP, spinach T2DM, type 2 diabetes; UB, non-blind. SS, Serial Subtractions, RVIP, Rapid Visual Information Processing; 
MFT, Mental Fatigue Test;  CST, Colour Stroop Test; SRT, Simple Reaction Time; SM, Shape Memory;  DRT,  Decision Reaction Time; 
SM, Spatial Memory ; DV,  Digit Vigilance ; CRT, Choice Reaction Time;  NWM,  Numeric Working Memory;  DWR, Delayed Work 
Recognition ; AST, Attention Switching Task;  SST, Spatial Span Task; TMT-A, Trail Making Tests A; TMT-B, Trail Making Test-B; NR, 
Number Recall; MR, memory recognition; ER, Emotion Recognition;  VS-1, Visual Interference; VB-1, Verbal Interference; MZ, Maze,  
CPT, Continuous Performance Test;  GNG, Go/No-Go. a These are abstracts and the quality assessment was not performed. 
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Table 2: Characteristics of the studies included in the systematic review and meta-analysis of the 
effects of dietary nitrate/nitrite on cerebral blood flow 
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n of 
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Exerc
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at 
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con
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J
a
d
a
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S
c
o
re 
Aam
and, 
2013 
De
nm
ark 
DB, 
Pl, 
,CO, 
R 
20 Healt
hy, 
Youn
g 
25 2
0 
7.7 SNA N
F-
S 
3 days - ASL NO No 
cha
ng
e 
- 2 
Bond
, 
2013 
US
A 
Pl, 
CO, 
R 
12 Healt
hy, 
Youn
g 
20 - 5-6 BJ OJ 120 min 24.4 
CVRI, 
MCAV 
YES Po
siti
ve  
Pos
itiv
e  
1 
Chiri
nos, 
2017 
US
A 
DB, 
CO, 
R, Pl 
17 HFp
EF 
65 1
4 
12.9 BJ N
D-
BJ 
150 min 34.4 
CCID, 
CCSA, 
CBVR
D 
NO Po
siti
ve  
- 4 
Curry
, 
2016 
US
A 
Pl, 
CO, 
R 
10 Healt
hy, 
Youn
g 
20 - 24.2 BJ OJ 120 min 23.5 MCAV YES Po
siti
ve 
Pos
itiv
e 
1 
Leffe
rts, 
2015 
US
A 
DB, 
CO, 
R, Pl 
20 Healt
hy, 
Youn
g 
23 2
0 
6.5-7.0 BJ N
D-
BJ 
120 min 24.6 MCAV YES No 
cha
ng
e 
No 
cha
nge 
3 
Presl
ey, 
2011 
US
A 
R,C
O 
16 Healt
hy, 
Old 
≥ 
70 
N
R 
12.4 High 
nitrate 
diet 
Lo
w 
nit
rat
e 
di
et 
2 days - ASL NO Po
siti
ve 
(re
gin
al 
cer
ebr
al 
per
fus
ion
) 
- 2 
Rattr
ay, 
2015a 
Au
str
ali
a 
DB, 
CO, 
R, Pl 
12 Healt
hy, 
Youn
g 
- - 13 BJ N
D-
BJ 
120 min - 
MCAV 
YES Po
siti
ve  
- - 
Tho
mpso
n, 
2014 
U
K 
DB, 
CO, 
R, Pl 
16 Healt
hy, 
Youn
g 
24 1
6 
5 BJ B
CJ
+
AJ 
90 min 24.1 NIRS YES Po
siti
ve 
Pos
itiv
e 
3 
Wigh
tman, 
2015 
U
K 
P, 
DB, 
R, Pl 
40 Healt
hy, 
Youn
g 
21 1
2 
5.5 BJ B
CJ
+
AJ 
90 min 24 NIRS NO Po
siti
ve 
Ne
gat
ive 
3 
BCJ+AJ, blackcurrant cordial JUICE and apple juice; OJ, Orange juice; SN, Sodium Nitrate; NF-S, Nitrate free solution; BJ, Beetroot juice; 
ND-BJ, Nitrate depleted beetroot juice BMI, body mass index; CO, crossover; DB, double-blind; NF-C, nitrite free capsules; P, Parallel; Pl, 
placebo-controlled; R, Randomized SB, single-blind; ASL, Arterial spin labelling; CVRI, Cerebrovascular resistance index; SBP, Systolic 
blood pressure; TVR, Total vascular resistance; MCAV, Middle cerebral artery blood flow velocity; HFpEF, Heart failure preserved left 
ventricular ejection fraction; CCID, Carotid characteristic impedance, dynes; CCSA, Carotid cross-sectional area; CBVRD, Carotid bed 
vascular resistance, dynes. a This is an abstract and the quality assessment was not performed. 
  
 
 
 
 
 
 
 
31 
 
 
Table 3: Meta-regression analysis to evaluate whether age, BMI, dose of nitrate and duration 
of the intervention modified the effects of nitrate/ nitrite supplementation on cognitive and 
cerebral blood flow  
 Slope (β)  SE  Q (df) P 
Cognitive function (n= 13) 
Age (years) -0.002 0.003 0.92 (1) 0.33 
BMI (kg/m
2
) -0.02 0.02 1.38 (1) 0.23 
Dose (mg/day) 0.002 0.004 0.22 (1) 0.63 
Duration (hours) 0.0005 0.0002 3.20 (1) 0.07 
Jadad 0.30 0.18 2.85 (1) 0.09 
Resting CBF (n= 9) 
Age (years) 0.001 0.006 0.09 (1) 0.98 
BMI (kg/m
2
) 0.02 0.032 0.58 (1) 0.45 
Dose (mg/day) -0.02 0.023 0.43(1) 0.51 
Duration (hours) -0.001 0.0006 5.07 (1) 0.02 
Jadad 0.03 0.13 0.06 (1) 0.79 
BMI, Body Mass Index; SE, standard error; CBF, cerebral blood flow. 
 
 
 
 
 
 
 
 
